company
Genzyme Ireland Limited
Industry: biotech
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · cgmp2026-06-22Genzyme Ireland Limited — CGMP/Deviations/Biologics License Application (BLA) (2026-06-22)
- fda_483 · inspection_citation2025-01-17Genzyme Ireland Limited -- FDA 483: 1 observation (2025-01-17)
Frequently asked questions
- How many FDA warning letters has Genzyme Ireland Limited received?
- Argus HQ has recorded 1 FDA warning letter for Genzyme Ireland Limited.
- What FDA recalls has Genzyme Ireland Limited issued?
- Argus HQ has not recorded an FDA recall tied to Genzyme Ireland Limited in our current dataset.
- Is Genzyme Ireland Limited FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Genzyme Ireland Limited. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.